Yesterday, Oct. 8, 2015, 33 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $370.00 to $7,976,778.07.

Highlighted Stocks Traded by Insiders:

Jason Industries (JASN) - FREE Research Report

Wynnefield Partners Small Cap Value Lp, who is 10% Owner at Jason Industries, bought 1,600 shares at $4.50 on Oct. 8, 2015. Following this transaction, the 10% Owner owned 100,000 shares meaning that the stake was boosted by 1.63% with the 1,600-share transaction.

The shares most recently traded at $4.92, up $0.42, or 8.54% since the insider transaction. Historical insider transactions for Jason Industries go as follows:

  • 4-Week # shares bought: 73,115
  • 12-Week # shares bought: 156,981
  • 12-Week # shares sold: 3,400
  • 24-Week # shares bought: 178,295
  • 24-Week # shares sold: 3,400

The average volume for Jason Industries has been 37,800 shares per day over the past 30 days. Jason Industries has a market cap of $104.7 million and is part of the industrial goods sector and industrial industry. Shares are down 52.08% year-to-date as of the close of trading on Thursday.

Jason Industries, Inc., together with its subsidiaries, engages in the manufacture of seating, finishing, acoustics, and components in the United States and internationally. Currently, there are 2 analysts who rate Jason Industries a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JASN - FREE

TheStreet Quant Ratings

rates Jason Industries as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally high debt management risk, generally disappointing historical performance in the stock itself and poor profit margins. Get the full

Jason Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Retrophin (RTRX) - FREE Research Report

Shih Alvin, who is EVP of Research & Development at Retrophin, sold 8,750 shares at $20.12 on Oct. 8, 2015. Following this transaction, the EVP of Research & Development owned 193,334 shares meaning that the stake was reduced by 4.33% with the 8,750-share transaction.

The shares most recently traded at $19.25, down $0.87, or 4.53% since the insider transaction. Historical insider transactions for Retrophin go as follows:

  • 4-Week # shares bought: 15,000
  • 4-Week # shares sold: 27,916
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 27,916
  • 24-Week # shares bought: 15,000
  • 24-Week # shares sold: 27,916

The average volume for Retrophin has been 584,800 shares per day over the past 30 days. Retrophin has a market cap of $713.8 million and is part of the health care sector and drugs industry. Shares are up 63.15% year-to-date as of the close of trading on Thursday.

Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases. Currently, there is 1 analyst who rates Retrophin a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RTRX - FREE

TheStreet Quant Ratings

rates Retrophin as a

sell

. Among the areas we feel are negative, one of the most important has been unimpressive growth in net income over time. Get the full

Retrophin Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Rosetta Stone (RST) - FREE Research Report

Verses Judy, who is Pres., Global Enterp. & Educ'n at Rosetta Stone, sold 1,613 shares at $6.48 on Oct. 8, 2015. Following this transaction, the Pres., Global Enterp. & Educ'n owned 50,478 shares meaning that the stake was reduced by 3.1% with the 1,613-share transaction.

The shares most recently traded at $6.93, up $0.45, or 6.49% since the insider transaction. Historical insider transactions for Rosetta Stone go as follows:

  • 4-Week # shares sold: 1,286
  • 12-Week # shares sold: 1,286
  • 24-Week # shares sold: 4,818

The average volume for Rosetta Stone has been 71,900 shares per day over the past 30 days. Rosetta Stone has a market cap of $153.5 million and is part of the technology sector and computer software & services industry. Shares are down 28.59% year-to-date as of the close of trading on Thursday.

Rosetta Stone Inc., together with its subsidiaries, provides technology-based learning products in the United States and internationally. It operates through three segments: North America Consumer, Rest of World Consumer, and Global Enterprise & Education. Currently, there is 1 analyst who rates Rosetta Stone a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on RST - FREE

TheStreet Quant Ratings

rates Rosetta Stone as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Rosetta Stone Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.